NCT04222907

Brief Summary

Determination of GBS colonization rates in Pregnant Women insured with Maccabi Health Services, Doctors' Compliance Rates for Referral for Testing, test execution rates, and Early-onset GBS Disease (EOGBSD) Rates in Israel. Determine the relationship between conducting a GBS test in pregnant women and EOGBSD in Israel.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54,759

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2015

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2016

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 7, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 10, 2020

Completed
Last Updated

January 13, 2020

Status Verified

April 1, 2017

Enrollment Period

1.7 years

First QC Date

January 7, 2020

Last Update Submit

January 9, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Attack rate of early-onset GBS disease (EOGBSD)

    Attack rate of (EOGBSD)

    2015-2016

Study Arms (2)

Women screened for GBS

All women who were pregnant during 2015-2016 and delivery was between 37-42 weeks who were screened for GBS during pregnancy

Women not screened for GBS

All women who were pregnant during 2015-2016 and delivery was between 37-42 weeks who were not screened for GBS during pregnancy

Eligibility Criteria

Sexfemale
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Full-term pregnancies were defined as gestational age 37 weeks and above. Pregnancies were identified by a pregnancy code accessed by the primary physician indicating that the patient is pregnant, open pregnancy record in the medical record or child linked to the mother's id. Gestational age was defined by last menstrual period (LMP) or first obstetric ultrasound if LMP was unknown.We identified and excluded repeat pregnancies occurring in the same woman during the time period, multiple pregnancies, gestational age greater than 42 weeks due to probability of data inaccuracy and women with missing information.

You may qualify if:

  • All women with term pregnancies from 2015 to 2016 (until 20/9/16) insured by Maccabi Healthcare Services (MHS)

You may not qualify if:

  • repeat pregnancies occurring in the same woman during the time period
  • multiple pregnancies
  • gestational age greater than 42 weeks due to probability of data inaccuracy
  • women with missing information

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
20 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2020

First Posted

January 10, 2020

Study Start

January 1, 2015

Primary Completion

September 20, 2016

Study Completion

September 20, 2019

Last Updated

January 13, 2020

Record last verified: 2017-04